HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M L Boshuisen Selected Research

6-chloro-2-(1-piperazinyl)pyrazine (CPP)

9/2000Zolmitriptan (a 5-HT1B/1D receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M L Boshuisen Research Topics

Disease

2Panic Disorder (Panic Attack)
03/2002 - 11/2001
1Personality Disorders (Personality Disorder)
01/2019
1Pain (Aches)
11/2001
1Weight Gain
11/2001
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
09/2000

Drug/Important Bio-Agent (IBA)

2Mirtazapine (Rexer)FDA LinkGeneric
03/2002 - 11/2001
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
11/2001
1Serotonin (5 Hydroxytryptamine)IBA
09/2000
1zolmitriptan (Zomig)FDA Link
09/2000
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
09/2000
11-(3-chlorophenyl)piperazineIBA
09/2000

Therapy/Procedure

1Therapeutics
01/2019
1Drug Therapy (Chemotherapy)
03/2002